• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

围手术期死亡率:一项对75446例非心脏手术患者的回顾性队列研究。

Perioperative Mortality: A Retrospective Cohort Study of 75,446 Noncardiac Surgery Patients.

作者信息

Nuttall Gregory A, Merren Michael P, Naranjo Julian, Portner Erica R, Ambrose Amanda R, Rihal Charanjit S

机构信息

Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN.

Department of Cardiovascular Disease, Mayo Clinic, Rochester, MN.

出版信息

Mayo Clin Proc Innov Qual Outcomes. 2024 Aug 21;8(5):435-442. doi: 10.1016/j.mayocpiqo.2024.07.002. eCollection 2024 Oct.

DOI:10.1016/j.mayocpiqo.2024.07.002
PMID:39263428
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11387539/
Abstract

OBJECTIVE

To evaluate whether major adverse cardiac events (MACE) continue to be a major causative factor for mortality after noncardiac surgery.

PATIENTS AND METHODS

We performed retrospective study of 75,410 adult noncardiac surgery patients at Mayo Clinic Rochester, between January 1, 2016, and May 4, 2018. Electronic medical records were reviewed and data collected on all deaths within 30 days (n=692 patients) of surgery. The incidence of death due to MACE was calculated.

RESULTS

Postoperative MACE occurred in 150 patients (21.4 events per 10,000 patients; 95% CI, 18.2-25.2 events per 10,000 patients) with most occurring within 3 days of surgery (n=113). Postoperative MACE events were associated with atrial fibrillation with rapid rate response in 25 patients (16.7%), sepsis in 15 patients (10%), and bleeding in 15 patients (10%). There were 12 intraoperative deaths of which 9 were due to exsanguination (75%) and the remaining 3 (25%) due to cardiac arrest. Of the 56 deaths on the first 24 hours after surgery, 7 were due to hemorrhage, 17 due to cardiovascular causes, 20 due to sepsis, and 7 due to neurologic disease. The leading cause of total death over 30 days postoperatively was sepsis (28%), followed by malignancy (27%), cardiovascular disease (12%) neurologic disease (12%), and hemorrhage (5%).

CONCLUSION

MACE was not the leading cause of death both intraoperatively and postoperatively.

摘要

目的

评估主要不良心脏事件(MACE)是否仍然是非心脏手术后死亡的主要原因。

患者与方法

我们对2016年1月1日至2018年5月4日在梅奥诊所罗切斯特分院接受非心脏手术的75410例成年患者进行了回顾性研究。回顾电子病历并收集手术30天内所有死亡患者(n = 692例)的数据。计算因MACE导致的死亡率。

结果

术后发生MACE的患者有150例(每10000例患者中发生21.4例;95%CI,每10000例患者中发生18.2 - 25.2例),大多数发生在术后3天内(n = 113例)。术后MACE事件与快速心率反应性房颤相关的有25例(16.7%),脓毒症相关的有15例(10%),出血相关的有15例(10%)。术中死亡12例,其中9例死于失血(75%),其余3例(25%)死于心脏骤停。术后24小时内死亡的56例患者中,7例死于出血,17例死于心血管原因,20例死于脓毒症,7例死于神经系统疾病。术后30天内总死亡的主要原因是脓毒症(28%),其次是恶性肿瘤(27%)、心血管疾病(12%)、神经系统疾病(12%)和出血(5%)。

结论

MACE并非术中和术后死亡的主要原因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/079b/11387539/14bbe85510ca/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/079b/11387539/14bbe85510ca/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/079b/11387539/14bbe85510ca/gr1.jpg

相似文献

1
Perioperative Mortality: A Retrospective Cohort Study of 75,446 Noncardiac Surgery Patients.围手术期死亡率:一项对75446例非心脏手术患者的回顾性队列研究。
Mayo Clin Proc Innov Qual Outcomes. 2024 Aug 21;8(5):435-442. doi: 10.1016/j.mayocpiqo.2024.07.002. eCollection 2024 Oct.
2
EVALUATION OF PERIOPERATIVE HIGH-SENSITIVE CARDIAC TROPONIN I AS A PREDICTIVE BIOMARKER OF MAJOR ADVERSE CARDIOVASCULAR EVENTS AFTER NONCARDIAC SURGERY.评估非心脏手术后围手术期高敏心肌肌钙蛋白 I 作为主要不良心血管事件的预测性生物标志物。
Rev Invest Clin. 2020;72(2):110-118. doi: 10.24875/RIC.19002888.
3
Association of β-blocker therapy with risks of adverse cardiovascular events and deaths in patients with ischemic heart disease undergoing noncardiac surgery: a Danish nationwide cohort study.β 受体阻滞剂治疗与非心脏手术缺血性心脏病患者不良心血管事件和死亡风险的关联:一项丹麦全国队列研究。
JAMA Intern Med. 2014 Mar;174(3):336-44. doi: 10.1001/jamainternmed.2013.11349.
4
One-year Outcomes after Discharge from Noncardiac Surgery and Association between Predischarge Complications and Death after Discharge: Analysis of the VISION Prospective Cohort Study.非心脏手术后出院一年的结局以及出院前并发症与出院后死亡之间的关联:VISION前瞻性队列研究分析
Anesthesiology. 2024 Jan 1;140(1):8-24. doi: 10.1097/ALN.0000000000004763.
5
Risk of major adverse cardiac events following noncardiac surgery in patients with coronary stents.冠状动脉支架置入术后非心脏手术患者的主要不良心脏事件风险。
JAMA. 2013 Oct 9;310(14):1462-72. doi: 10.1001/jama.2013.278787.
6
Evaluation of Perioperative High-Sensitive Cardiac Troponin I as a Predictive Biomarker of Major Adverse Cardiovascular Events After Noncardiac Surgery.围手术期高敏心肌肌钙蛋白I作为非心脏手术后主要不良心血管事件预测生物标志物的评估
Rev Invest Clin. 2020 May 7;73(3).
7
Major adverse cardiac events in elderly patients with coronary artery disease undergoing noncardiac surgery: A multicenter prospective study in China.老年冠心病患者非心脏手术中的主要不良心脏事件:一项中国的多中心前瞻性研究。
Arch Gerontol Geriatr. 2015 Nov-Dec;61(3):503-9. doi: 10.1016/j.archger.2015.07.006. Epub 2015 Aug 3.
8
The comparative and added prognostic value of biomarkers to the Revised Cardiac Risk Index for preoperative prediction of major adverse cardiac events and all-cause mortality in patients who undergo noncardiac surgery.生物标志物对改良心脏风险指数在预测非心脏手术患者主要不良心脏事件和全因死亡率方面的比较和附加预后价值。
Cochrane Database Syst Rev. 2021 Dec 21;12(12):CD013139. doi: 10.1002/14651858.CD013139.pub2.
9
Risk factors for perioperative major cardiac events in Chinese elderly patients with coronary heart disease undergoing noncardiac surgery.中国老年冠心病患者非心脏手术后围术期主要心脏事件的危险因素。
Chin Med J (Engl). 2013;126(18):3464-9.
10
Patients with single ventricle physiology undergoing noncardiac surgery are at high risk for adverse events.患有单心室生理状况的患者在接受非心脏手术时发生不良事件的风险很高。
Paediatr Anaesth. 2015 Aug;25(8):846-851. doi: 10.1111/pan.12685. Epub 2015 May 13.

本文引用的文献

1
5-Lead Electrocardiogram Monitoring to Detect Perioperative Myocardial Infarction, Noncardiac Surgery Patients.用于检测非心脏手术患者围手术期心肌梗死的五导联心电图监测
Mayo Clin Proc. 2023 Oct;98(10):1581-1582. doi: 10.1016/j.mayocp.2023.08.004.
2
Predicting Death or Disability after Surgery in the Older Adult.预测老年患者手术后的死亡或残疾。
Anesthesiology. 2023 Oct 1;139(4):420-431. doi: 10.1097/ALN.0000000000004683.
3
Perioperative strategies to reduce risk of myocardial injury after non-cardiac surgery (MINS): A narrative review.
非心脏手术围手术期降低心肌损伤风险(MINS)的策略:一项叙述性综述。
J Clin Anesth. 2023 Aug;87:111106. doi: 10.1016/j.jclinane.2023.111106. Epub 2023 Mar 15.
4
Trends and In-Hospital Mortality for Perioperative Myocardial Infarction After the Introduction of a Diagnostic Code for Type 2 Myocardial Infarction in the United States Between 2016 and 2018.2016 年至 2018 年美国引入 2 型心肌梗死诊断代码后,围手术期心肌梗死的趋势和院内死亡率。
Anesth Analg. 2024 Feb 1;138(2):420-429. doi: 10.1213/ANE.0000000000006404. Epub 2023 Feb 16.
5
Frailty Assessment and Perioperative Major Adverse Cardiovascular Events After Noncardiac Surgery.非心脏手术后的虚弱评估和围手术期主要不良心血管事件。
Am J Med. 2023 Apr;136(4):372-379.e5. doi: 10.1016/j.amjmed.2022.12.033. Epub 2023 Jan 16.
6
Clinical Impact of High-Sensitivity Cardiac Troponin T Implementation in the Community.社区中实施高敏心肌肌钙蛋白 T 的临床影响。
J Am Coll Cardiol. 2021 Jun 29;77(25):3160-3170. doi: 10.1016/j.jacc.2021.04.050. Epub 2021 May 3.
7
Opportunities and Challenges for the Next Phase of Enhanced Recovery After Surgery: A Review.术后强化恢复下一阶段的机遇与挑战:综述
JAMA Surg. 2021 Aug 1;156(8):775-784. doi: 10.1001/jamasurg.2021.0586.
8
Association Between Short-, Intermediate-, and Long-term Mortality and Myocardial Injury After Noncardiac Surgery After Hip Fracture Surgery: A Retrospective Cohort.髋部骨折手术后非心脏手术后短期、中期和长期死亡率与心肌损伤的关系:一项回顾性队列研究。
Anesth Analg. 2021 Oct 1;133(4):915-923. doi: 10.1213/ANE.0000000000005528.
9
Intraoperative Hypotension and Myocardial Infarction Development Among High-Risk Patients Undergoing Noncardiac Surgery: A Nested Case-Control Study.非心脏手术高危患者术中低血压与心肌梗死发生情况:一项巢式病例对照研究
Anesth Analg. 2021 Jul 1;133(1):6-15. doi: 10.1213/ANE.0000000000005391.
10
Two Decades Since To Err Is Human: Progress, but Still a "Chasm".自《人非圣贤,孰能无过》发表二十年以来:虽有进步,但仍存“鸿沟”。
JAMA. 2020 Dec 22;324(24):2489-2490. doi: 10.1001/jama.2020.23151.